In practice, potential benefits are not universal: it depends on the context (diet, nutritional status, training level or medical conditions)
ni kh ro, thong mt , trnh nh nng trc tip
It depends on your health and what your doctor recommends
This question concerns many patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management
Concomitant use of semaglutide with insulin or insulin secretagogues may result in hypoglycemia, and a dose reduction in the concomitant medication may be necessary